Identification of Rotavirus VP6-Specific CD4+ T Cell Epitopes in a G1P[8] Human Rotavirus-Infected Rhesus Macaque.
A non-human primate model was used to evaluate its potential for identification of rotavirus viral protein 6 (VP6) CD4+ T cell epitopes. Four juvenile rhesus macaques were inoculated with a mixed inoculum (G1P[8] and G9P[8]) of human rotaviruses. Infection accompanied by G1P[8] shedding was achieved in the two macaques that had no rotavirus immunoglobulin A (IgA) in plasma. To measure the interferon gamma (IFN-γ) and tumor necrosis factor (TNF) anti-viral cytokines produced by peripheral CD4+ cells that recognize VP6 epitopes, whole blood cells from one infected macaque were stimulated in vitro with VP6 peptides. Stimulation with peptide pools derived from the simian rotavirus VP6(161-395) region revealed reactivity of CD4+ T cells with the VP6(281-331) domain. A VP6(301-315) region was identified as the epitope responsible for IFN-γ production while a broader VP6(293-327) domain was linked to TNF production. These results suggest that human rotavirus-infected macaques can be used for identification of additional epitopes and domains to address specific questions related to the development of pediatric vaccines.
Zhao
Wei
W
Tulane National Primate Research Center, Covington, LA, U.S.A.
Pahar
Bapi
B
Sestak
Karol
K
Arch Virol. 1976;50(1-2):17-27
816334
J Virol. 1997 Nov;71(11):8707-17
9343229
Am J Vet Res. 1980 Jul;41(7):1098-1103
6254409
J Clin Microbiol. 1992 Jun;30(6):1365-73
1320625
J Clin Microbiol. 1990 Feb;28(2):276-82
2155916
Vaccine. 2006 Nov 17;24(47-48):6839-49
17050045
J Med Virol. 2005 Apr;75(4):616-25
15714478
Vet Immunol Immunopathol. 2002 Sep 10;87(3-4):147-60
12072229
Emerg Infect Dis. 2003 May;9(5):565-72
12737740
J Virol. 2000 Dec;74(24):11574-80
11090155
J Virol. 2002 May;76(10):4741-9
11967291
J Virol. 2004 Oct;78(19):10258-64
15367591
Immunol Rev. 2001 Oct;183:76-85
11782248
Virol J. 2006 May 31;3:40
16737519
J Virol. 2006 May;80(10):4949-61
16641286
J Virol. 1998 Apr;72(4):2708-14
9525588
Virology. 2003 Jan 5;305(1):93-105
12504544
Virology. 2007 Jul 5;363(2):410-8
17337285
J Virol. 1991 May;65(5):2562-71
1850029
J Clin Microbiol. 1994 Jul;32(7):1820-2
7929782
J Virol. 2004 Oct;78(20):10967-76
15452217
J Virol. 2002 Jan;76(2):560-8
11752147
J Virol. 1998 Jan;72(1):330-8
9420231
Clin Infect Dis. 2002 May 15;34(10):1351-61
11981731
Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):253-69
17698192
Virology. 2005 Oct 25;341(2):248-56
16095646
J Virol. 1995 Dec;69(12):7800-6
7494291
Immunogenetics. 1997;45(3):171-9
8995183
Gut. 1977 Feb;18(2):156-60
192637
Virology. 2002 Mar 15;294(2):256-69
12009867
Virology. 2003 Sep 30;314(2):671-9
14554094
Infection. 1978;6(2):71-2
206515
J Virol. 2005 Jan;79(2):944-54
15613323
J Virol. 2005 Apr;79(8):4568-79
15795243
J Immunol Methods. 2001 Sep 1;255(1-2):27-40
11470284
Tissue Antigens. 2000 Jul;56(1):58-68
10958357
J Virol. 1997 Jan;71(1):419-26
8985366